News

BioPharma Dive7h
Abeona cell therapy approved by FDA for rare skin condition
Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...
Chromatography Online13h
Identifying TB Markers Using UHPLC–IMS-HRMS and Non-Invasive Skin Sampling
A non-invasive wearable sampler combined with UHPLC–IMS-HRMS has been developed to identify biomarkers for TB using human ...